Eugenol ameliorates insulin resistance, oxidative stress and inflammation in high fat-diet/streptozotocin-induced diabetic rat
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Background: Eugenol, a phenolic compound present in many plant essential oils, demonstrated anti‐diabetic activity but the underlying mechanisms are not fully understood. The aim of the present study was to examine the anti‐diabetic, anti‐oxidative and the anti‐inflammatory effect of eugenol in high‐fat‐diet (HFD) and streptozotocin (STZ)‐induced diabetic rats. Additionally, the effect of eugenol on the insulin sensitivity and on skeletal muscle protein contents of glucose transporter‐4 (GLUT4) and AMP‐activated protein kinase (AMPK) was investigated. Materials and methods: HFD/STZ‐induced diabetic rats were treated orally with eugenol (10mg/kg) for 45days. After the end of the experiment, blood and skeletal muscle samples were collected. Metformin was used as positive control. Results: The anti‐diabetic effects of eugenol were demonstrated by the significant reduction in the levels of serum glucose, triglyceride, cholesterol, Low‐density lipoprotein, malondialdehyde and interleukin‐6 in the treated group compared to the diabetic group. Additionally, eugenol treatment significantly restored the decreased serum levels of insulin and glutathione when compared to that of the diabetic control rats. The homeostasis model assessment of insulin resistance (HOMA‐IR) was significantly lower in rats treated with eugenol than in the diabetic rats. The skeletal muscle protein contents of GLUT4 and AMPK were higher in the eugenol treated group than in the diabetic control group. Conclusion: Eugenol possesses potent anti‐oxidative and anti‐inflammatory effect in HFD/STZ‐induced diabetic rats. Moreover, eugenol facilitates insulin sensitivity and stimulate skeletal muscle glucose uptake via activation of the GLUT4‐AMPK signaling pathway. Eugenol could represent a promising therapeutic agent to prevent type 2 diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnosis and classification of diabetes mellitus
American Diabetes Association (2014) · Diabetes Care · doi:10.2337/dc14-s081 · Cited by 5,974
C-Reactive Protein, Interleukin 6, and Risk of Developing Type 2 Diabetes Mellitus
Pradhan, A. D. (2001) · JAMA · doi:10.1001/jama.286.3.327 · Cited by 4,433
Inflammation, stress, and diabetes
Wellen, K. E., & Hotamisligil, G. S. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25102 · Cited by 4,143
Glucolipotoxicity: fuel excess and β-cell dysfunction
Poitout, V., & Robertson, R. P. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0023 · Cited by 1,092
Essential oil eugenol: Sources, extraction techniques and nutraceutical perspectives
Khalil, A. A., Rahman, U. U., Khan, M. R., Sahar, A., Mehmood, T., & Khan, M. (2017) · RSC Advances · doi:10.1039/c7ra04803c · Cited by 407
Phytotherapy in the management of diabetes: A review
Governa, P., Baini, G., Borgonetti, V., Cettolin, G., Giachetti, D., Magnano, A., Miraldi, E., & Biagi, M. (2018) · Molecules · doi:10.3390/molecules23010105 · Cited by 182
Lee, Y.-Y., Hung, S.-L., Pai, S.-F., Lee, Y.-H., & Yang, S.-F. (2007) · Journal of Endodontics · doi:10.1016/j.joen.2007.02.010 · Cited by 87
Cited by
Aleissa, M. S., Alkahtani, S., Abd Eldaim, M. A., Ahmed, A. M., Bungău, S. G., Almutairi, B., Bin-Jumah, M., AlKahtane, A. A., Alyousif, M. S., & Abdel-Daim, M. M. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/9316751 · Cited by 88
Ghule, S. N., & Desai, M. A. (2021) · Journal of Applied Research on Medicinal and Aromatic Plants · doi:10.1016/j.jarmap.2021.100325 · Cited by 22
Tomar, H., Rawat, A., Nagarkoti, K., Prakash, O., Kumar, R., Srivastava, R. M., Rawat, S., & Rawat, D. S. (2023) · South African Journal of Botany · doi:10.1016/j.sajb.2023.04.014 · Cited by 15
Metadata
- Authors
- Al-Trad, B., Alkhateeb, H., Alsmadi, W., & Al-Zoubi, M.
- Venue
- Life Sciences
- Publisher
- Elsevier BV
- Published
- 2019-01
- Volume
- 216
- Pages
- 183-188
- ISSN
- 0024-3205 (ISSN-L)
- OpenAlex
- W2901508016
- Cited by
- 125
- References
- 7
- FWCI
- 6.48
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.